Leukemia Program
The DF/HCC Program in Leukemia seeks to conduct innovative basic research on the pathogenesis of leukemia and related disorders, focusing on discoveries leading to improvements in diagnosis, prognosis, and therapy.
The aim of the Leukemia Program is to improve the prognosis of patients with leukemia through basic research, clinical investigation, and outcomes studies. To this end, the program has assembled laboratory researchers, translational scientists, clinical investigators interested in pathogenesis, epidemiology, or treatment of adult and pediatric patients with acute leukemias, myeloproliferative disorders, myelodysplasia, and related diseases.